โ† All deals

Warhound

defenseDefense TechBiotechSeed
๐Ÿ“ Texas, United States
StreetZero Signal 75
Be the first to signal interest

About Warhound

Warhound is a Texas-based defense technology company focused on rebuilding America's domestic supply of military working dogs through cloning, genetic screening, and biotechnology licensed from Colossal Biosciences. Founded by Ben Lamm of Colossal Biosciences, Palmer Luckey of Anduril, and George Church, the company combines advanced genetics with Anduril's cybernetic augments and software to create healthier, more capable working dogs for the U.S. military, law enforcement, and emergency responders. It aims to reduce reliance on foreign suppliers, currently the source of 80% of U.S. military dogs, and works with the American Humane Society on training and retirement programs.

LATEST FUNDINGSeed
$200.0M
Announced 2026-10-22
TOTAL RAISED$200M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for Warhound.

Free plan includes 3 full deal profiles every month.

Key highlights

  • Raised $200M seed at $1.2B valuation to engineer genetically enhanced military dogs.
  • Combines Colossal Biosciences' cloning and genetics with Anduril cybernetic augments.
  • Backed by In-Q-Tel, Sequoia, ARK Invest and other prominent defense and biotech investors.
  • Targets domestic U.S. supply to replace 80% of dogs currently sourced from Europe.
  • Partners with American Humane Society for training certification and post-service dog reunification.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account